Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 2 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Recs

0
Player Avatar steelersnextat7 (< 20) Submitted: 9/22/2009 2:10:56 AM : Outperform Start Price: $4.88 ACUR Score: -67.00

FDA approval is looming in Jan to March 2010 when it does acura will hit 12 to 15 or be bought or both king will scoop it up

Featured Broker Partners


Advertisement